International medical technology and cybersecurity company Sectra, together with its distribution partner Matsunami Glass, has begun implementing its first digital pathology project in Japan. This marks the company’s entry into the Japanese digital pathology market and underscores the potential of its technology to enhance diagnostic accuracy and accelerate patient care.
Health Technology Insights: Allink Biotherapeutics Secures $47Million Series A Extension
Torbjörn Kronander, President and CEO of Sectra AB, said that collaborating with Kameda Medical Center on this project is a major milestone for the company. He added that receiving the order from such a respected institution demonstrates Sectra’s commitment to supporting Japanese healthcare providers in adopting digital pathology and improving workflow efficiency for faster and more precise diagnostics.
The project at Kameda Medical Center comes after Sectra signed a contract in the second quarter of its 2025/2026 fiscal year through Matsunami Glass, the company’s distribution partner in Japan. The implementation will allow pathologists to access digital images of tissue samples instantly and remotely, replacing traditional glass slides and microscopes. This will enable more efficient review and collaboration on cases while leveraging AI tools integrated into the platform.
Health Technology Insights: Cosette Pharma Launches First Generic CIPRO HC with CGT Exclusivity
Professor Junya Fukuoka, Chair of the Department of Pathology at Kameda Medical Center, said that after nearly ten years as a fully digital pathology laboratory, the hospital is now moving to a comprehensive digital pathology platform. He emphasized that Sectra’s solution provides strong compatibility, interoperability, and secure handling of sensitive patient data, making it a natural choice for the hospital’s evolving needs.
This first project highlights Sectra’s focus on supporting healthcare organizations with advanced digital pathology solutions that improve diagnostic workflows, enhance collaboration, and help reduce the time required to deliver critical results to patients.
Health Technology Insights: Victor Miller Joins NorthStar Medical Radioisotopes, LLC as Chief Financial Officer
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
